Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
Rev. bras. epidemiol ; 24: e210011, 2021. tab, graf
Article in English | LILACS | ID: biblio-1156024

ABSTRACT

ABSTRACT: Objective: To develop a linkage algorithm to match anonymous death records of cancer of the larynx (ICD-10 C32X), retrieved from the Mortality Information System (SIM) and the Hospital Information System of the Brazilian Unified National Health System (SIH-SUS) in Brazil. Methodology: Death records containing ICD-10 C32X codes were retrieved from SIM and SIH-SUS, limited to individuals aged 30 years and over, between 2002 and 2012, in the state of São Paulo. The databases were linked using a unique key identifier developed with sociodemographic data shared by both systems. Linkage performance was ascertained by applying the same procedure to similar non-anonymous databases. True pairs were those having the same identification variables. Results: A total of 14,311 eligible death records were found. Most records, 10,674 (74.6%), were exclusive to SIM. Only 1,853 (12.9%) deaths were registered in both systems, representing true pairs. A total of 1,784 (12.5%) cases of laryngeal cancer in the SIH-SUS database were tracked in SIM with different causes of death. The linkage failed to match 167 (9.4%) records due to inconsistencies in the key identifier. Conclusion: The authors found that linking anonymous data from mortality and hospital records is a feasible measure to track missing records and may improve cancer statistics.


RESUMO: Objetivo: Desenvolver um algoritmo de vinculação de registros para parear registros de óbito por câncer de laringe (CID-10 C32X), recuperados do Sistema de Informação de Mortalidade (SIM) e do Sistema de Informações Hospitalares do Sistema Único de Saúde (SIH-SUS) do Brasil. Métodos: Foram filtrados registros de óbitos contendo códigos CID-10 C32X do SIM e do SIH-SUS, de indivíduos de mais de 30 anos, entre 2002 e 2012, no Estado de São Paulo. As bases de dados foram vinculadas por meio de um identificador único e de variáveis sociodemográficas comuns a ambos os sistemas. O desempenho da vinculação de dados foi aferido aplicando-se o mesmo procedimento em bancos de dados nominais. Os pares verdadeiros apresentavam os mesmos valores nas variáveis de identificação. Resultados: Ao todo, 14.311 registros elegíveis de óbito foram encontrados. A maioria dos registros, 10.674 (74.6%), era exclusiva do SIM. Apenas 1.853 (12.9%) óbitos foram registrados em ambos os sistemas, representando pares verdadeiros. Um total de 1.784 (12.5%) casos de câncer de laringe presentes no SIH-SUS constavam com diferentes causas de óbito no SIM. Houve falha na vinculação em 167 (9.4%) registros, devido a inconsistências na chave de identificação. Conclusão: Constatou-se que a vinculação de dados anônimos de registros hospitalares e registros de óbito é viável e pode auxiliar na melhoria de estatísticas de câncer.


Subject(s)
Humans , Adult , Laryngeal Neoplasms/mortality , Information Storage and Retrieval/methods , Algorithms , Brazil/epidemiology , Information Systems , Death Certificates , Feasibility Studies , Databases, Factual , Hospital Information Systems
2.
Rev. otorrinolaringol. cir. cabeza cuello ; 80(3): 286-294, set. 2020. tab, graf
Article in Spanish | LILACS | ID: biblio-1144891

ABSTRACT

Resumen Introducción: El cáncer laríngeo es una de las neoplasias de cabeza y cuello más frecuentes, asociado al envejecimiento y a los hábitos de vida. Los análisis de supervivencia de cáncer laríngeo en Chile son escasos. Objetivo: Calcular y analizar la supervivencia y las características clínicas del cáncer laríngeo en pacientes del Servicio de Otorrinolaringología del Hospital Carlos Van Buren, Valparaíso, Chile. Material y Método: Se realizó un estudio retrospectivo de cohorte, incluyendo pacientes diagnosticados con carcinoma escamoso de laringe entre 2007 y 2018. Se calculó la supervivencia con el método de Kaplan-Meier. Se aplicaron las pruebas de log rank, t de Student y exacta de Fisher. Resultados: Se incluyeron 211 pacientes, 90,52% hombres, con un promedio de edad de 68 años. El factor de riesgo más frecuente fue el tabaquismo. La ubicación tumoral más frecuente fue la glotis (59,44%) y el motivo de consulta más común la disfonía (52,66%). Un 70,48% presentó estadios avanzados. En 23,92% se realizó laringectomía total como tratamiento primario. La supervivencia global a 2 años fue de 86,6% en estadio precoz y 45,2% en estadio avanzado, mientras que a 5 años fue de 77,4% y 33%, respectivamente. Conclusión: La supervivencia estimada fue menor que en otros estudios nacionales, lo que puede asociarse al tamaño de la muestra analizada, a factores etarios y/o a mayor latencia de inicio de tratamiento. Se enfatiza el mejoramiento de los registros clínicos y la gestión sanitaria para un manejo oportuno.


Abstract Introduction: Laryngeal carcinoma is one of the most frequent head and neck neoplasms, being associated with ageing and lifestyles. In Chile, survival analyses of laryngeal carcinoma are scarce. Aim: To estimate and analyze the survival and clinical characteristics of laryngeal carcinoma in patients attended at the Otorhinolaryngology Department of the Carlos Van Buren Hospital, Valparaíso, Chile. Material and Method: We conducted a retrospective cohort study, including patients diagnosed with laryngeal squamous cell carcinoma between 2007 and 2018. Kaplan-Meier estimator was applied for survival analysis. Log rank test, Student's t-test and Fisher's exact test were applied. Results: 211 patients were included, 90,52% were men, with an average age of 68 years. The main risk factor was smoking (80%). The most frequent tumor location was in the glottis (59,44%) and the most frequent reason for consultation was dysphonia (52,66%). Most cases (70,48%) presented at advanced stages. Laryngectomy was performed as a primary treatment in 23,92%. The 2-year overall survival rate was 86,6% for early stages and 45,2% for advanced stages; the 5-year overall survival rate was 77,4% and 33%, respectively. Conclusion: The estimated survival rate was lower than those referred by other national studies, which may be associated with the analyzed sample size, age-related factors and/or period of latency until the beginning of treatment. We emphasize the necessity of an improvement in clinical records and the health management to the timely treatment.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/epidemiology , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/epidemiology , Chile/epidemiology , Laryngeal Neoplasms/therapy , Survival Rate , Retrospective Studies
3.
Braz. j. otorhinolaryngol. (Impr.) ; 86(3): 351-357, May-June 2020. tab, graf
Article in English | LILACS | ID: biblio-1132605

ABSTRACT

Abstract Introduction: Human papilloma virus is an etiological risk factor for a subset of head and neck squamous cell carcinomas. HPV has been proven to be a powerful prognostic biomarker for oropharyngeal cancer, but its role in the larynx has not been explored in depth. The developmental mechanisms of laryngeal carcinomas are quite complex and controlled by various factors. Smoking and alcohol are most important risk factors. Recent studies indicate that HPV infection also plays an important role in larynx carcinomas. HPV related laryngeal carcinomas especially occur at the supraglottic region of larynx. Objective: We aimed to determine the frequency of HPV/protein16 positivity in patients with laryngeal carcinoma and association of HPV and/or p16 positivity with variables such as age, sex, smoking habits, tumor localization, lymph node metastasis, recurrence and survival in advanced stage laryngeal carcinoma in our study. Methods: This retrospective study included 90 patients with advanced laryngeal carcinoma. The Control group was 10 normal larynx mucosa specimens. The presence of HPV was investigated polyclonally by polymerase chain reaction, and protein16 with immunohistochemical method. In HPV positive cases, the presence of HPV types 16, 18 were evaluated by polymerase chain reaction. Demographic features of patients were noted. Patient survival and association with HPV/protein16 was determined. Results: Polyclonal HPV positivity was detected in 11 (12.2%) of 90 cases. Out of these 11 cases, HPV 16 was positive in 6, HPV 18 in 4, and both HPV 16 and 18 were positive in 1. In 18 (20%) of the cases, p16 was positive. Six of the cases (6.6%) had both HPV and protein16 positivity. In cases where protein16 alone or HPV and protein16 were co-positive, alcohol use was less and the tumor was found more likely to be localized in the supraglottic area. These ratios were statistically significant. Supraglottic localization of tumor was determined to be increased in protein16 positive cases. The correlation between protein16 positivity and supraglottic area location was determined to be statistically significant (p= 0.011). 55.6% of protein16 positive cases was located in the supraglottic region, 33.3% was glottic and 11.1% was transglottic. Although life expectancy over 5 years were numerically higher in HPV and protein16 positive cases, this was not found to be statistically significant. There was no statistically significant relationship between HPV positivity and mean age, differentiation, smoking and alcohol use, tumor progression, lymph node metastasis, localization, recurrence, cause of mortality and treatment methods in our study. The mean follow-up period of our patients was 6.7 years. Conclusion: The close relationship between HPV and oropharyngeal squamous cell carcinoma could not be shown in larynx malignancy in many studies, including our study. Our findings support a limited role of HPV in laryngeal carcinogenesis. Protein16 is not a reliable surrogate for HPV status in laryngeal cancers and is not a predictor of laryngeal cancer survival. Supraglottic localization of tumor was determined to be increased in protein16 positive cases. The correlation between protein16 positivity and supraglottic area location was determined to be statistically significant. There is a need for more populated clinical trials, where neoplastic proliferation is better demonstrated and the accuracy of the results obtained is supported by different techniques.


Resumo Introdução: O papilomavírus humano é um fator de risco etiológico para um subconjunto de carcinoma espinocelular de cabeça e pescoço. Tem sido demonstrado que o HPV é um poderoso biomarcador prognóstico para o câncer de orofaringe, mas seu papel na laringe ainda não foi explorado em profundidade. Os mecanismos de desenvolvimento dos carcinomas de laringe são bastante complexos e controlados por vários fatores. Tabagismo e álcool são os fatores de risco mais importantes. Estudos recentes indicam que a infecção pelo HPV também desempenha um papel importante nos carcinomas da laringe. Os carcinomas laríngeos relacionados ao HPV ocorrem especialmente na região supraglótica. Objetivo: Nosso objetivo foi determinar a frequência da positividade para o HPV / proteína 16 em pacientes com carcinoma da laringe e a associação da positividade para o HPV e /ou proteína 16 com variáveis como idade, sexo, tabagismo, localização do tumor, metástase linfonodal, recidiva e sobrevivência de carcinoma da laringe em estágio avançado em nosso estudo. Método: Este estudo retrospectivo incluiu 90 pacientes com carcinoma laríngeo avançado. O grupo controle incluiu 10 amostras de mucosa laríngea normal. A presença de HPV foi inves-tigada por anticorpo policlonal através de reação de polimerase em cadeia e a proteína 16 por método imunohistoquímico. Nos casos positivos para o HPV, a presença dos tipos 16 e 18 do foi avaliada por reação de polimerase em cadeia. As características demográficas dos pacientes foram observadas. A sobrevida dos pacientes e a associação com HPV / proteína 16 foram determinadas. Resultados: A positividade com anticorpo policlonal do HPV foi detectada em 11 (12,2%) dos 90 casos. Desses 11 casos, o HPV 16 foi positivo em 6, o HPV 18 em 4 e o HPV 16 e 18 foram positivos em 1. Em 18 (20%) dos casos, a proteína 16 foi positiva. Seis dos casos (6,6%) apresentaram positividade para HPV e proteína16. Nos casos positivos apenas para a proteína 16 ou quando HPV e a proteína 16 foram co-positivos, a ingestão de álcool foi menor e o tumor apresentou maior probabilidade de estar localizado na área supraglótica. Essas proporções foram estatisticamente significantes. A localização supraglótica do tumor foi maior em casos positivos para proteína 16. A correlação entre positividade para proteína 16 e localização da área supraglótica foi estatisticamente significante (p = 0,011). Dos casos positivos para proteína 16, 55,6% foram supraglóticos, 33,3% glóticos e 11,1% transglóticos. Embora a expectativa de vida acima de 5 anos tenha sido numericamente maior nos casos positivos para HPV e proteína 16, isso não foi estatisticamente significante. Não houve relação estatisticamente significante entre positividade do HPV e média de idade, diferenciação, tabagismo e uso de álcool, progressão tumoral, metástase linfonodal, localização, recidiva, causa de mortalidade e métodos de tratamento em nosso estudo. O período médio de seguimento de nossos pacientes foi de 6,7 anos. Conclusão: A estreita relação entre HPV e carcinoma espinocelular orofaríngeo não pôde ser demonstrada na laringe em muitos estudos, inclusive no nosso estudo. Nossos achados confirmam um papel limitado do HPV na carcinogênese da laringe. A proteína 16 não é um substituto confiável para o status do HPV nos cânceres de laringe e não é preditor da sobrevida do câncer de laringe. A localização supraglótica do tumor foi maior em casos positivos para proteína16. A correlação entre positividade para proteína 16 e localização na área supraglótica foi determinada como estatisticamente significante. Há necessidade de ensaios clínicos com amostras maiores, nos quais a proliferação neoplásica seja melhor demonstrada e a precisão dos resultados obtidos seja apoiada por diferentes técnicas.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Laryngeal Neoplasms/blood , Laryngeal Neoplasms/virology , Cyclin-Dependent Kinase Inhibitor p16/blood , Human papillomavirus 16/genetics , Human papillomavirus 18/genetics , Prognosis , Laryngeal Neoplasms/mortality , Retrospective Studies , Risk Factors , Neoplasm Staging
4.
Rev. Hosp. Ital. B. Aires (2004) ; 40(1): 4-10, mar. 2020. ilus, tab
Article in Spanish | LILACS | ID: biblio-1100756

ABSTRACT

Se realizó un estudio prospectivo y descriptivo, incluyendo 103 pacientes que fueron tratados por cáncer de laringe en etapa inicial (T1-T2) con cirugía transoral. De ellos, 55 se diagnosticaron en estadio T1, 16 en estadio T1-b y 32 en estadio T2. El control local inicial (CLI) en pacientes con tumores malignos de laringe estadificados T1 fue 91%, el control local con rescate (CLR) 96%, la preservación de la función de la laringe (PFL) 93% y la sobrevida específica 96%. En T1-b, el CLI fue 81%, el CLR 94%, la PFL 94% y la sobrevida específica 94%. En T2, el CLI fue 63%, el CLR 94%, la PFL 72% y la sobrevida específica 78%. La cirugía transoral en cáncer de laringe con T inicial tiene resultados oncológicos similares a otros tratamientos (cirugía externa o radioterapia), pero consideramos que es la mejor opción por su baja morbilidad, menor duración del tratamiento, y porque deja abiertas todas las posibilidades para tratar posibles recurrencias. (AU)


A prospective and descriptive study was conducted, including 103 patients who were treated for early stage laryngeal cancer (T1-T2) with transoral surgery. Of these, 55 were diagnosed in stage T1, 16 in stage T1-b and 32 in stage T2. The initial local control (CLI) in patients with malignant T1 laryngeal tumors was: 91%, local control with rescue (CLR) 96%, preservation of larynx function (PFL) 93% and specific survival 96%. In T1-b the CLI was 81%, the CLR 94%, the PFL 94% and the specific survival 94%. In T2 the CLI was 63%, the CLR 94%, the PFL 72% and the specific survival 78%. Transoral surgery in laryngeal cancer with initial T has oncological results similar to other treatments (external surgery or radiotherapy), but we consider that it is the best option because of its low morbidity, shorter duration of treatment, and because it leaves open all the possibilities to treat possible recurrences. (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Laryngeal Neoplasms/surgery , Neoplasm Recurrence, Local/prevention & control , Postoperative Complications/prevention & control , Surgical Procedures, Operative/methods , Vocal Cords/pathology , Voice Quality , Tracheostomy/statistics & numerical data , Laryngeal Neoplasms/classification , Laryngeal Neoplasms/diagnosis , Laryngeal Neoplasms/physiopathology , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/radiotherapy , Prospective Studies , Epiglottis/pathology , Duration of Therapy , Intubation, Gastrointestinal/statistics & numerical data
5.
Braz. j. otorhinolaryngol. (Impr.) ; 85(5): 603-610, Sept.-Oct. 2019. tab, graf
Article in English | LILACS | ID: biblio-1039288

ABSTRACT

Abstract Introduction: The treatment of laryngeal squamous cell carcinoma needs accurate risk stratification, in order to choose the most suitable therapy. The prognostic significance of resection margin is still highly debated, considering the contradictory results obtained in several studies regarding the survival rate of patients with a positive resection margin. Objective: To evaluate the prognostic role of resection margin in terms of survival and risk of recurrence of primary tumour through survival analysis. Methods: Between 2007 and 2014, 139 patients affected by laryngeal squamous cell carcinoma underwent partial or total laryngectomy and were followed for mean of 59.44 ± 28.65 months. Resection margin status and other variables such as sex, age, tumour grading, pT, pN, surgical technique adopted, and post-operative radio- and/or chemotherapy were investigated as prognostic factors. Results: 45.32% of patients underwent total laryngectomy, while the remaining subjects in the cohort underwent partial laryngectomy. Resection margins in 73.39% of samples were free of disease, while in 21 patients (15.1%) anatomo-pathological evaluation found one of the margins to be close; in 16 subjects (11.51%) an involved resection margin was found. Only 6 patients (4.31%) had a recurrence, which occurred in 83.33% of these patients within the first year of follow-up. Disease specific survival was 99.24% after 1 year, 92.4% after 3 years, and 85.91% at 5 years. The multivariate analysis of all covariates showed an increased mortality rate only with regard to pN (HR = 5.043; p = 0.015) and recurrence (HR = 11.586; p = 0.012). Resection margin did not result an independent predictor (HR = 0.757; p = 0.653). Conclusions: Our study did not recognize resection margin as an independent prognostic factor; most previously published papers lack unanimous, methodological choices, and the cohorts of patients analyzed are not easy to compare. To reach a unanimous agreement regarding the prognostic value of resection margins, it would be necessary to carry out meta-analyses on studies sharing definition of resection margin, methodology and post-operative therapeutic choices.


Resumo Introdução: O tratamento do carcinoma de células escamosas de laringe necessita de uma estratificação precisa do risco, para a escolha da terapia mais adequada. O significado prognóstico da margem de ressecção ainda é motivo de debate, considerando-se os resultados contraditórios obtidos em vários estudos sobre a taxa de sobrevida de pacientes com margem de ressecção positiva. Objetivo: Avaliar o papel prognóstico da margem de ressecção em termos de sobrevida e risco de recorrência de tumor primário através da análise de sobrevida. Método: Entre 2007 e 2014, 139 pacientes com carcinoma de células escamosas de laringe foram submetidos à laringectomia parcial ou total e foram acompanhados por um tempo médio de 59,44 ± 28,65 meses. O status de margem de ressecção e outras variáveis, como sexo, idade, grau do tumor, pT, pN, técnica cirúrgica adotada e radio- e/ou quimioterapia pós-operatória, foram investigados como fatores prognósticos. Resultados: Dos pacientes, 45,32% foram submetidos à laringectomia total, enquanto os demais foram submetidos à laringectomia parcial. As margens de ressecção em 73,39% das amostras estavam livres, enquanto em 21 pacientes (15,1%) a avaliação anatomopatológica encontrou uma das margens próxima e 16 indivíduos (11,51%) apresentaram margem de ressecção comprometida. Apenas seis pacientes (4,31%) apresentaram recidiva, o que ocorreu em 83,33% desses pacientes no primeiro ano de seguimento. A sobrevida doença-específica foi de 99,24% em um ano, 92,4% em três anos e 85,91% em cinco anos. A análise multivariada de todas as covariáveis mostrou um aumento na taxa de mortalidade apenas em relação à pN (HR = 5,043; p = 0,015) e recidiva (HR = 11,586; p = 0,012). A margem de ressecção não demonstrou ser um preditor independente (HR = 0,757; p = 0,653). Conclusões: Nosso estudo não identificou a margem de ressecção como fator prognóstico independente; a maioria dos artigos publicados anteriormente não tem escolhas metodológicas unânimes e as coortes de pacientes analisados não são fáceis de comparar. Para chegar a uma concordância unânime em relação ao valor prognóstico da margem de ressecção, seria necessário fazer metanálises em estudos que compartilham a definição da margem de ressecção, metodologia e escolhas terapêuticas pós-operatórias.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/surgery , Laryngeal Neoplasms/surgery , Margins of Excision , Prognosis , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Survival Analysis , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/pathology , Survival Rate , Retrospective Studies , Italy/epidemiology , Laryngectomy/methods , Neoplasm Recurrence, Local
6.
Braz. j. otorhinolaryngol. (Impr.) ; 85(3): 357-364, May-June 2019. tab, graf
Article in English | LILACS | ID: biblio-1011629

ABSTRACT

Abstract Introduction: Although the red cell distribution width has been reported as a reliable predictor of prognosis in several types of cancer, to our knowledge few reports have focused on the prognostic value of red cell distribution width in laryngeal carcinoma. Objective: We aimed to explore whether the pretreatment red cell distribution width predicted recurrence in laryngeal cancer patients is a simple, reproducible, and inexpensive prognostic biomarker. Methods: All laryngeal cancer patients who underwent curative surgery (n = 132) over a 7 year study period were evaluated. Data on demographics, primary tumor site, T-stage, N-stage, histological features (differentiation; the presence of perineural/perivascular invasion), treatment group (total laryngectomy or partial laryngectomy) or adjuvant therapy (chemotherapy/radiotherapy); laboratory parameters (complete blood count, including the pre-operative red cell distribution width), and disease-free survival rates were retrospectively reviewed. All cases were divided into three groups by the red cell distribution width tertile [<13% (25th percentile) (n = 31), 13-14.4% (50th percentile) (n = 72), and >14.4% (75th percentile) (n = 29)]. Results: High-red cell distribution width group included more patients of advanced age, and more of those with recurrent and metastatic tumors (p = 0.005, 0.048, and 0.043, respectively). Individuals with red cell distribution width >14.4% (75th percentile) had lower disease free survival rates than did those with red cell distribution width <13% (25th percentile) (p = 0.014). Patients with red cell distribution width >14.4% at diagnosis were at a higher risk of locoregional recurrence (hazard ratio = 5.818, 95% confidence interval (95% CI) 1.25-26.97; p = 0.024) than patients with a normal red cell distribution width (<13%). Conclusion: We found that the pretreatment red cell distribution width was independently prognostic of disease free survival rate in patients with laryngeal cancer and may serve as a new, accurate, and reproducible means of identifying early-stage laryngeal cancer patients with poorer prognoses.


Resumo Introdução: Embora a amplitude de distribuição de eritrócitos tenha sido relatada como um preditor confiável de prognóstico em vários tipos de câncer, que seja de nosso conhecimento, poucos estudos se concentraram no valor prognóstico dessa medida no carcinoma laríngeo. Objetivo: Avaliar se a amplitude de distribuição de eritrócitos pré-tratamento prevê a recorrência em pacientes com câncer de laringe como um biomarcador prognóstico simples, reprodutível e não dispendioso. Método: Foram avaliados todos os pacientes com câncer de laringe submetidos à cirurgia curativa (n = 132) durante sete anos. Dados demográficos, local do tumor primário, estágio T, estágio N, características histológicas (diferenciação; presença de invasão perineural/perivascular), grupo de tratamento (laringectomia total ou laringectomia parcial) ou terapia adjuvante (quimioterapia/radioterapia); parâmetros laboratoriais (hemograma, inclusive a amplitude de distribuição de eritrócitos pré-operatório) e a sobrevida livre de doença foram revisados retrospectivamente. Todos os casos foram divididos em três grupos pelo tercil da amplitude de distribuição de eritrócitos [< 13% (percentil 25) (n = 31), 13%-14,4% (percentil 50) (n = 72) e > 14,4% (percentil 75) (n = 29)]. Resultados: O grupo com amplitude de distribuição de eritrócitos elevado incluiu um número maior de pacientes com idade avançada e mais pacientes com tumores recorrentes e metastáticos (p = 0,005, 0,048 e 0,043, respectivamente). Os indivíduos com a amplitude de distribuição de eritrócitos > 14,4% (percentil 75) apresentaram taxas de sobrevida livre de doença menores do que aqueles com a amplitude de distribuição de eritrócitos < 13% (percentil 25) (p = 0,014). Pacientes com a amplitude de distribuição de eritrócitos > 14,4% no diagnóstico apresentaram maior risco de recorrência locorregional [Hazard Ratio = 5,818, intervalo de confiança de 95% (IC 95%) 1,25-26,97; p = 0,024] do que pacientes com a amplitude de distribuição de eritrócitos normal (< 13%). Conclusão: Verificamos que a amplitude de distribuição de eritrócitos pré-tratamento foi um fator prognóstico independente de sobrevida livre de doença em pacientes com câncer de laringe e pode servir como um novo parâmetro, preciso e reprodutível, para identificar pacientes com câncer de laringe em estágio inicial com piores prognósticos.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/blood , Laryngeal Neoplasms/blood , Erythrocyte Indices , Prognosis , Carcinoma, Squamous Cell/surgery , Carcinoma, Squamous Cell/mortality , Laryngeal Neoplasms/surgery , Laryngeal Neoplasms/mortality , Predictive Value of Tests , Retrospective Studies , Disease-Free Survival , Laryngectomy , Neoplasm Recurrence, Local , Neoplasm Staging
7.
Rev. otorrinolaringol. cir. cabeza cuello ; 78(4): 406-412, dic. 2018. tab, graf
Article in Spanish | LILACS | ID: biblio-985746

ABSTRACT

RESUMEN Introducción: Dentro de los factores que juegan un rol en la supervivencia y recidiva de enfermedad de los pacientes con cáncer laríngeo escamoso operados se encuentra el tiempo de inicio de la radioterapia (RT) posoperatoria. Objetivo: Determinar el impacto del retraso de inicio de RT posoperatoria en la supervivencia y recidiva de enfermedad en pacientes con cáncer de laringe escamoso avanzado operado. Material y método: Estudio tipo cohorte retrospectiva. Recolección de datos mediante revisión de fichas clínicas. Análisis de supervivencia y recidiva de enfermedad mediante el método de Kaplan-Meier, comparación de curvas con prueba de Log-Rank y modelo de regresión de Cox para análisis de factores pronósticos. Resultados: El tiempo de espera entre la cirugía y el inicio de la RT en nuestras realidades hospitalarias fueron 11 semanas. La supervivencia específica a 5 años en los pacientes que comienzan la RT ≤6 semanas desde la cirugía es de 33,3% y disminuye a 20% en aquellos que la comienzan >6 semanas (p =0,20). Conclusión: Los pacientes que inician la RT en más de 6 semanas desde la cirugía no presentan una diferencia estadísticamente significativa en el pronóstico.


ABSTRACT Introduction: Among the factors that play a role in the survival and recurrence of disease of patients with operated squamous laryngeal cancer is the time to initiation of postoperative radiotherapy (RT). Aim: To determine the impact of delayed onset of postoperative RT on survival and disease recurrence in patients with advanced operated squamous laryngeal cancer. Material and Method: Retrospective cohort study. Collection of data through review of clinical records. Analysis of survival and disease recurrence using the Kaplan-Meier method, comparison of curves with Log-Rank test and Cox regression model for analysis of prognostic factors. Results: The waiting time between surgery and the initiation of RT in our hospital realities was 11 weeks. The 5-year specific survival in patients who start RT ≤ 6 weeks after surgery is 33.3% and decreases to 20% in those who start > 6 weeks (p = 0.20). Conclusion: Patients who start RT in more than 6 weeks after surgery do not present a statistically significant difference in prognosis.


Subject(s)
Humans , Male , Female , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/radiotherapy , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/radiotherapy , Radiotherapy, Adjuvant , Postoperative Care , Recurrence , Carcinoma, Squamous Cell/surgery , Chile/epidemiology , Laryngeal Neoplasms/surgery , Retrospective Studies , Survivorship
8.
Braz. j. otorhinolaryngol. (Impr.) ; 84(5): 566-573, Sept.-Oct. 2018. tab, graf
Article in English | LILACS | ID: biblio-974348

ABSTRACT

Abstract Introduction: Soft tissue deposits is tumorous islands apart from lymph nodes and occasionally diagnosed in neck dissection specimens. Their importance has begun to be recognized, however, their value has not been investigated in laryngeal cancer as a single tumor site. Objective: To investigate the prognostic value of soft tissue deposits in patients with laryngeal carcinoma. Methods: Medical records of 194 patients with laryngeal carcinoma who were treated primarily by surgery and neck dissection were reviewed. Prognostic significance of soft tissue deposits was assessed along with other clinical and pathological findings. Recurrence rates, overall and disease-specific survival rates were examined. Results: The incidence of soft tissue deposits was found to be 7.2% in laryngeal carcinoma. N stage was more advanced in patients who had soft tissue deposits. Regional recurrence rate was higher and disease specific and overall survivals rates were significantly lower in patients with soft tissue deposits in univariate analysis. However, in multivariate analysis, soft tissue deposits were not found as an independent risk factor. Conclusion: In laryngeal carcinoma, soft tissue deposits was diagnosed in patients with more advanced neck disease and their significance was lesser than other factors including extranodal extension.


Resumo Introdução: Depósitos de tecido mole são ilhas tumorais diferente dos linfonodos e ocasionalmente diagnosticados em amostras de esvaziamento cervical. Sua importância começou a ser reconhecida, mas seu valor não foi investigado no câncer de laringe como um único local de tumor. Objetivo: Investigar o valor prognóstico do depósito de tecido mole em pacientes com carcinoma laríngeo. Método: Os prontuários de 194 pacientes com carcinoma laríngeo tratados principalmente por cirurgia e esvaziamento cervical foram analisados. O significado prognóstico dos depósitos de tecido mole foi avaliado juntamente com outros achados clínicos e histopatológicos. As taxas de recidiva, as taxas de sobrevida geral e específicas da doença foram avaliadas. Resultados: Observou-se uma incidência de depósitos de tecido mole de 7,2% no carcinoma laríngeo. O estágio N foi mais avançado em pacientes com depósitos de tecido mole. A taxa de recorrência regional foi maior e as taxas de sobrevida geral e específica da doença foram significativamente menores nesses pacientes na análise univariada. No entanto, na análise multivariada, o depósito de tecido mole não foi observado como um fator de risco independente. Conclusão: No carcinoma laríngeo, o depósito de tecido mole foi diagnosticado em pacientes com doença cervical mais avançada, mas sua significância foi menor do que outros fatores, inclusive a extensão extranodal.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Aged, 80 and over , Soft Tissue Neoplasms/secondary , Laryngeal Neoplasms/pathology , Prognosis , Neck Dissection , Brazil/epidemiology , Carcinoma, Squamous Cell/surgery , Carcinoma, Squamous Cell/pathology , Laryngeal Neoplasms/surgery , Laryngeal Neoplasms/mortality , Survival Rate , Risk Factors , Lymphatic Metastasis/pathology
9.
Rev. Assoc. Med. Bras. (1992) ; 63(12): 1082-1089, Dec. 2017. tab
Article in English | LILACS | ID: biblio-896324

ABSTRACT

Summary Introduction: Since the beginning of the 1990s, non-surgical radiochemotherapy treatment has become popular with the prospect of maintaining oncological results and preserving the organ in patients with advanced squamous cell carcinoma of the larynx and hypopharynx. However, subsequent studies demonstrated increased recurrence and mortality after the non-surgical treatment became popular. Objective: To compare the oncological results of surgical and non-surgical treatments of patients with larynx and hypopharynx cancer and to evaluate the variables associated with disease recurrence. Method: This is a retrospective cohort study of 134 patients undergoing surgical (total or partial laryngectomy) or non-surgical (isolated radiotherapy, chemotherapy or induction chemotherapy followed by radiotherapy and chemotherapy) treatment, with 62 patients in the surgical group and 72 in the non-surgical group. Results: Disease-free survival rates were higher in the surgical group (81.7% vs. 62.2%; p=0.028), especially in III/IV stages (p=0.018), locally advanced tumors T3 and T4a (p=0.021) and N0/N1 cases (p=0.005). The presence of cervical lymph nodes, especially N2/N3, was considered a risk factor for disease recurrence in both groups (HR=11.82; 95CI 3.42-40.88; p<0.0001). Patients not undergoing surgical treatment were 3.8 times more likely to develop recurrence (HR=3.76; 95CI 1.27-11.14; p=0.039). Conclusion: Patients with larynx or hypopharynx cancer non-surgically treated had a poorer disease-free survival, especially in cases with locally advanced tumors (T3 and T4a) and in which the neck was only slightly affected (N0/N1).


Resumo Introdução: A partir de estudos do início dos anos 1990, popularizou-se o tratamento não cirúrgico com radioquimioterapia, com a perspectiva de manutenção do resultado oncológico e preservação do órgão em pacientes com carcinoma espinocelular avançado de laringe e hipofaringe. Entretanto, estudos posteriores demonstraram aumento da recorrência e da mortalidade com a difusão do tratamento não cirúrgico. Objetivo: Comparar o resultado oncológico dos tratamentos cirúrgico e não cirúrgico de pacientes com câncer de laringe e hipofaringe e avaliar as variáveis associadas à recidiva de doença. Método: Estudo de coorte retrospectiva de pacientes submetidos ao tratamento cirúrgico (laringectomia total ou parcial) e não cirúrgico (radioterapia isolada, radioterapia concomitante a quimioterapia ou quimioterapia de indução seguida de radioterapia e quimioterapia) de 134 pacientes, sendo 62 no grupo cirúrgico e 72 no não cirúrgico. Resultados: As taxas de sobrevivência livre de doença foram maiores no grupo cirúrgico (81,7% vs. 62,2%; p=0,028), principalmente em estádios III/IV (p=0,018), tumores localmente avançados T3 e T4a (p=0,021) e casos N0/N1 (p=0,005). A presença de linfonodos cervicais, principalmente N2/N3, foi considerada fator de risco para recidiva de doença nos dois grupos (HR=11,82; IC95% 3,42-40,88; p<0,0001). Pacientes não submetidos ao tratamento cirúrgico apresentaram 3,8 vezes mais chance de desenvolvimento de recidiva (HR=3,76; IC95% 1,27-11,14; p=0,017). Conclusão: Pacientes com câncer de laringe ou hipofaringe tratados de forma não cirúrgica tiveram menor sobrevivência livre de doença, especialmente nos tumores localmente avançados (T3 e T4a) e com pescoço pouco comprometido (N0/N1).


Subject(s)
Humans , Male , Female , Aged , Carcinoma, Squamous Cell/surgery , Hypopharyngeal Neoplasms/surgery , Laryngeal Neoplasms/surgery , Organ Sparing Treatments , Time Factors , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/radiotherapy , Hypopharyngeal Neoplasms/mortality , Hypopharyngeal Neoplasms/pathology , Hypopharyngeal Neoplasms/radiotherapy , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/pathology , Laryngeal Neoplasms/radiotherapy , Retrospective Studies , Disease-Free Survival , Hypopharynx/pathology , Laryngectomy , Larynx/pathology , Middle Aged , Neoplasm Staging
11.
Rev. otorrinolaringol. cir. cabeza cuello ; 77(1): 107-112, mar. 2017.
Article in Spanish | LILACS | ID: biblio-845655

ABSTRACT

Actualmente se realiza un diagnóstico anual de 650.000 nuevos casos de carcinoma escamoso de cabeza y cuello en el mundo, siendo el carcinoma escamoso de laringe una patología neoplásica que compete al otorrinolaringólogo. La incidencia mundial del cáncer escamoso de laringe se estima en 3,9 por cada 100.000 habitantes con una mortalidad general de 2,0 por cada 100.000 habitantes. En Chile el registro de cáncer se realiza en base a los cinco registros poblacionales de cáncer que existen. No se tienen datos exactos respecto a incidencia y mortalidad por carcinoma escamoso de laringe, siendo la estimación de la incidencia de 1,2 casos por cada 100.000 habitantes y la estimación de mortalidad ajustada por edad de 0,7 casos por cada 100.000 habitantes. Se han descrito diversos factores de riesgo ambientales y estilos de vida para este cáncer, por lo tanto, las estrategias de prevención primaria en salud son claves a la hora de generar un impacto en la incidencia del carcinoma escamoso de laringe.


The annual diagnosis of head and neck squamous cell carcinoma is 650,000 new cases. The laryngeal carcinoma is a malignant disease that should include an otolaryngologist in its evaluation. The global incidence of laryngeal carcinoma is estimated at 3.9 per 100,000 inhabitants with an overall mortality rate of 2.0 per 100,000 inhabitants. In Chile the cancer registry is based on the five population cancer registries that exist. There is no accurate data on incidence and mortality from laryngeal carcinoma, being an estimated incidence of 1.2 cases per 100,000 inhabitants and an age-adjusted mortality of 0.7 cases per 100.00 inhabitants. There have been described various environmental risk factors and lifestyles for this cancer, therefore, primary prevention strategies are key to generate an impact on the incidence of larynx carcinoma.


Subject(s)
Humans , Carcinoma, Squamous Cell/mortality , Laryngeal Neoplasms/mortality , Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/prevention & control , Chile/epidemiology , Diseases Registries , Incidence , Laryngeal Neoplasms/epidemiology , Laryngeal Neoplasms/prevention & control , Risk Factors
12.
Braz. j. otorhinolaryngol. (Impr.) ; 80(3): 245-250, May-June/2014. tab, graf
Article in English | LILACS | ID: lil-712975

ABSTRACT

INTRODUCTION: Basaloid squamous cell carcinoma (BSCC) is a rare subtype of squamous cell carcinoma (SCC). Because of its rarity, both clinical and prognostic features of this variant are not well known. OBJECTIVE: In this study, we aimed to determine the frequency of BSCC and other SCC variants among all laryngeal SCC cases, and to determine clinical and prognostic features of BSCC variant. Study design: retrospective cohort study. Evidence level: Level 2b. MATERIAL AND METHODS: Records of the patients who had laryngeal SCC surgically treated at our institute between 2007 and 2013 were retrospectively reviewed. RESULTS: Among 198 subjects who had laryngeal SCC surgically treated, the frequency of the variants of SCC other than classical variant was 10.1% (20/198). The most common SCC variant was BSCC (6.6%). Eleven (84.6%) patients with BSCC were at an advanced stage at the presentation (p > 0.05). The 3-year overall survival and disease-free survival rates were 63% and 53% respectively. CONCLUSION: BSCC variant may be more common than previously reported. Since almost the half of patients experiences disease recurrence in the early period, multimodal treatment strategies should be employed at initial treatment, and a close follow-up is strongly recommended for this aggressive SCC variant. .


INTRODUÇÃO: O carcinoma escamoso basaloide (CEB) é um raro subtipo do carcinoma de célula escamosa (CCE). Em decorrência de sua raridade, os aspectos clínicos e prognósticos dessa variante não são bem conhecidos. OBJETIVO: Determinar a frequência de CEB e de outras variantes do CCE entre todos os casos de CCE da laringe, assim como os aspectos clínicos e prognósticos da variante CEB. MÉTODOS: Trata-se de um estudo de coorte retrospectivo. Nível de evidência: 2b Os registros dos pacientes tratados cirurgicamente para CCE de laringe em nossa instituição entre 2007 e 2013 foram retrospectivamente revisados. RESULTADOS: Foram anotados 198 pacientes tratados cirurgicamente para CCE de laringe. A frequência das variantes de CCE diferentes da variante clássica foi 10,1% (20/198). A variante de CCE mais comum foi CEB (6,6%). Por ocasião da apresentação inicial, 11 (84,6%) pacientes com CEB estavam em estágio avançado (p > 0,05). Os percentuais de sobrevida geral após três anos e de sobrevida livre da doença foram 63% e 53%, respectivamente. CONCLUSÃO: A variante CEB pode ser mais comum do que o informado anteriormente. Considerando que praticamente metade dos pacientes sofre recorrência da doença em seu período inicial, devem ser introduzidas estratégias terapêuticas multimodais no tratamento inicial; além disso, recomendamos enfaticamente um cuidadoso seguimento para essa agressiva variante do CCE. .


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Carcinoma, Basosquamous/pathology , Carcinoma, Squamous Cell/pathology , Laryngeal Neoplasms/pathology , Cohort Studies , Carcinoma, Basosquamous/mortality , Carcinoma, Squamous Cell/mortality , Disease-Free Survival , Laryngeal Neoplasms/mortality , Neoplasm Staging , Prognosis , Retrospective Studies
13.
Indian J Cancer ; 2014 Jan-Mar; 51(1): 10-14
Article in English | IMSEAR | ID: sea-154273

ABSTRACT

PURPOSE: Concurrent chemoradiation is the current standard of care in locally advanced head and neck cancer. But, in our setup, many patients of carcinoma larynx are treated with only radical radiotherapy because of poor general condition of the patients. This study was performed to assess the influence radical radiotherapy alone on functional preservation of larynx. MATERIALS AND METHODS: 110 previously untreated patients with invasive squamous cell carcinoma of larynx were treated with radical radiotherapy alone between January 2006 and June 2009. Conventional one daily fraction of 2 Gy with total doses of 60–66 Gy was used. Voice preservation and local control at median follow-up period of 2 years were analyzed. Several host, tumor, and treatment parameters were also analyzed. RESULTS: Among 110 patients, preservation of larynx was possible in 78 patients (71%). With radical radiotherapy alone, excellent preservation of larynx was achieved in stage I (88.9%) and stage II (75%) disease, while in advanced stages, results were not so encouraging. In stage III and stage IVA, larynx preservation was only 72.4% and 65.3%, respectively. Patients without any cartilage invasion had significantly better laryngeal preservation rate as compared to patients with cartilage invasion. (78.9% vs. 35.3%; P = 0.008). CONCLUSION: Though concurrent chemoradiation is the standard of care in preservation of voice in laryngeal cancer, definitive radiotherapy alone may also be a good option in terms of preservation of larynx in patients of laryngeal cancer in community practice in the developing world where most of the patients cannot tolerate concurrent chemoradiation.


Subject(s)
Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/radiotherapy , Female , Follow-Up Studies , Humans , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/pathology , Laryngeal Neoplasms/radiotherapy , Male , Middle Aged , Neoplasm Recurrence, Local/mortality , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/radiotherapy , Neoplasm Staging , Organ Sparing Treatments , Prognosis , Retrospective Studies , Survival Rate , Voice Disorders/prevention & control
14.
Braz. j. otorhinolaryngol. (Impr.) ; 78(4): 59-65, jul.-ago. 2012. ilus, tab
Article in Portuguese | LILACS | ID: lil-646772

ABSTRACT

Muitos estudos relatam o aumento da expressão de S100 A7 (psoriasina) em lesões neoplásicas. Destacam-se trabalhos em carcinoma da mama, espinocelular da bexiga, pele e cavidade oral. Não foi demonstrada expressão da S100 A7 em câncer de laringe. OBJETIVO: Identificar a expressão da proteína ligadora de cálcio S100 A7 e sua correlação com carcinomas espinocelular da laringe. MATERIAL E MÉTODOS: Amostras de tecido neoplásico de 63 pacientes foram submetidos à imunohis toquímica com o anticorpo S110 A7. Os resultados foram classificados e comparados. RESULTADOS: O grupo bem diferenciado teve a maior pontuação de falha no tratamento. O grupo moderadamente diferenciado apresentou escores mais elevados do que o grupo pouco diferenciado. Pontuações mais altas predominaram nos estágios I e II no grupo moderadamente diferenciado, enquanto a distribuição do escore foi mais homogênea em estados avançados (III e IV). Em relação às falhas no tratamento, o grupo pontuação zero (04/03 complicações: 75%) diferiu significativamente da pontuação restante (13/59: 22%). CONCLUSÕES: A S100 A7 foi expressa em 93,7% dos casos de câncer de laringe, com maior positividade nos tumores mais diferenciados e taxa significativamente menor de falha no tratamento. A pontuação obtida não teve impacto sobre a sobrevivência.


Many studies have reported increased expression of S100 A7 (psoriasin) in neoplastic lesions. Among them are studies on breast carcinoma, bladder squamous cell carcinoma, skin tumors and oral cavity squamous cell carcinoma. The expression of S100 A7 has not been described for laryngeal cancer. OBJECTIVE: This study aims to identify the expression of the calcium-binding protein S100 A7 and its correlation with squamous cell carcinomas of the larynx. MATERIAL AND METHODS: Specimens from 63 patients were submitted to immunohistochemistry testing with antibody S100 A7. Results were classified and compared. RESULTS: The group with highly differentiated tumors had the highest treatment failure scores. Moderately differentiated tumors had higher treatment failure scores than poorly differentiated tumors. Higher scores were predominantly seen on stages I and II in moderately differentiated tumors, whereas score distribution was more homogeneous in advanced stage disease (III and IV). Regarding failure in treatment, the group scoring zero (3/4 complications: 75%) differed significantly from the remaining groups (13/59: 22%). CONCLUSIONS: S100 A7 marker was expressed in 93.7% of laryngeal cancer cases, with higher positive correlation rates in more differentiated tumors and significantly lower rates of treatment failure. Scores had no impact on survival rates.


Subject(s)
Adult , Aged , Female , Humans , Middle Aged , Carcinoma, Squamous Cell/metabolism , Laryngeal Neoplasms/metabolism , Neoplasm Proteins/metabolism , /metabolism , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Immunohistochemistry , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/pathology , Neoplasm Recurrence, Local , Neoplasm Staging , Neoplasm Proteins/analysis , /analysis , Survival Analysis , Biomarkers, Tumor/analysis , Biomarkers, Tumor/metabolism
15.
Rev. otorrinolaringol. cir. cabeza cuello ; 71(1): 7-13, abr. 2011. ilus, tab
Article in Spanish | LILACS | ID: lil-591993

ABSTRACT

Introducción: El cáncer de laringe es la segunda neoplasia maligna más frecuente en cabeza y cuello, existiendo varias alternativas terapéuticas para su manejo entre las que destaca el uso de láser para los estadios tempranos. Objetivo: Evaluar los resultados oncológicos de los pacientes con diagnóstico de cáncer de laringe que se trataron mediante microcirugía transoral láser en el Hospital Barros Luco. Material y método: Estudio retrospectivo de 30 pacientes operados en el Hospital Barros Luco desde el año 2003 al año 2009. Resultados: Para los pacientes con tumor T1 se obtuvo una sobrevida global (ajustada), control local inicial y final de 100 por ciento. En los pacientes T2 se observó una sobrevida global de 100 por ciento con un control local inicial y final de 81,8 por ciento. Los pacientes T3 también describieron una sobrevida global de 100 por ciento pero sin lograr control local inicial y final en ninguno de los pacientes. Discusión: Los resultados de control oncológico obtenidos en nuestro Servicio para estadios tempranos son similares a lo descrito en la literatura. Conclusiones: La cirugía transoral láser es un procedimiento seguro y con resultados oncológicos aceptables para el manejo de pacientes con patología neoplásica de laringe en estadios tempranos.


Introduction: Laryngeal cancer is the second most common malignancy in head and neck, and there are several treatment options for their management, wherein the use of lasers for early stages. Aim: To evaluate the oncological results of patients with a diagnosis of laringeal cancer, they were treated by transoral laser microsurgery at Hospital Barros Luco. Material and method: Retrospective study of 30 medical records of patients operated at the Barros Luco Hospital from 2003 to 2009. Results: For patients with T1 tumor overall survival (adjusted) initial and final local control of 100 percent was obtained. In T2 patients overall survival was 100 percent with an initial and final local control of 81.8 percent. Patients T3 described a 100 percent overall survival but without achieving local control and final control in none of the patients. Discussion: Cancer control results obtained in our service for early stages are similar to those described in the literature. Conclusions: Transoral laser surgery is a safe procedure with acceptable oncological outcomes in management of patients with neoplastic disease of the larynx in early stages.


Subject(s)
Humans , Male , Female , Middle Aged , Microsurgery/methods , Laryngeal Neoplasms/surgery , Laser Therapy/methods , Survival Analysis , Postoperative Complications , Retrospective Studies , Risk Factors , Neoplasm Invasiveness , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/pathology , Neoplasm Recurrence, Local , Reoperation , Treatment Outcome , Length of Stay
16.
Braz. j. otorhinolaryngol. (Impr.) ; 76(2): 225-230, mar.-abr. 2010. graf, tab
Article in English, Portuguese | LILACS | ID: lil-548325

ABSTRACT

No carcinoma epidermoide de laringe em estádios clínicos precoces (I e II), tanto a cirurgia quanto a radioterapia resultam em controle loco-regional significativo. Nos tumores avançados (III e IV), a radioterapia exclusiva tem índices de 32-43 por cento de controle loco-regional. OBJETIVO: É avaliar a sobrevida livre de doença dos pacientes com CEC de laringe submetidos à radioterapia exclusiva e/ou associada à quimioterapia. CASUÍSTICA E MÉTODOS: Estudo retrospectivo de 84 casos de CEC de laringe tratados com radioterapia ou quimioterapia concomitante à radioterapia. Cinquenta e três casos foram tratados com intenção curativa e 31 por irressecabilidade da doença. Quanto ao estádio clínico (EC), 12 eram de EC I, 15 II, 21 III e 5 IV. No segundo grupo, 11 casos eram EC III e 20 IV. RESULTADOS: Idade média foi de 60 anos, sendo 84,5 por cento homens. Cinquenta e oito (69,1 por cento) casos tiveram resposta completa e 26 (30,9 por cento) apresentavam doença persistente ou residual. A sobrevida livre de doença há cinco anos foi de 42,5 por cento, sendo de 62,5 por cento nos pacientes com indicação de preservação de órgãos e 9,75 no grupo de doença irressecável. CONCLUSÃO: A sobrevida livre de doença a cinco anos dos pacientes submetidos à radioterapia por CEC de laringe foi de 62,5 por cento.


In early stage (I and II) laryngeal squamous cell carcinoma, both surgery and radiotherapy results in significant local and regional control. In advanced tumors (III and IV), radiotherapy alone has local-regional control rates of 32-43 percent. AIM: To assess disease-free survival in SCC laryngeal carcinoma patients submitted to radiotherapy alone and/or associated with chemotherapy. MATERIALS AND METHODS: Retrospective study involving 84 cases of laryngeal SCC treated with radiotherapy or chemotherapy together with radiotherapy. Fifty-three cases were treated with intension to cure and 31 because of impossibility to resect the disease. As to clinical stage (CS), 12 were CS I, 15 II, 21 III and 5 IV. In the second group, 11 cases were EC III and 20 IV. RESULTS: Mean age was 60 years, 84.5 percent were men. Fifty-eight (69.1 percent) cases had complete response and 26 (30.9 percent) had persistent or residual disease. Five-year disease-free survival was of 42.5 percent; 62.5 percent of the patients with organ preservation indication and 9.75 in the group of irressecable disease. CONCLUSION: disease-free survival of those patients submitted to radiotherapy because of laryngeal SCC was of 62.5 percent


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/radiotherapy , Laryngeal Neoplasms/mortality , Laryngeal Neoplasms/radiotherapy , Carcinoma, Squamous Cell/drug therapy , Combined Modality Therapy/methods , Disease-Free Survival , Laryngeal Neoplasms/drug therapy , Neoplasm Staging , Radiotherapy Dosage , Retrospective Studies
17.
Rev. cuba. salud pública ; 35(3): 0-0, jul.-set. 2009. tab, mapas
Article in Spanish | LILACS | ID: lil-525582

ABSTRACT

Introducción Cuba se encuentra entre los países con más altas tasas de incidencia y mortalidad por cáncer de laringe. Objetivos Identificar la distribución geográfica de la incidencia y mortalidad del cáncer de laringe durante el período 1999-2004. Métodos Se tomaron los casos nuevos reportados al Registro Nacional de Cáncer durante el período 1999-2003 y los fallecidos del período 2000-2004. Se estimaron las Razones de Incidencia y Mortalidad promedio Estandarizada por edades para ambas etapas. Como riesgo estándar se tomaron las tasas específicas promedio de incidencia y mortalidad por grupos de edades de Cuba para los períodos respectivos. Se realizó la representación cartográfica del riego estimado. Resultados El riesgo de enfermar y morir fue más alto en hombres que en mujeres. En hombres el riesgo de enfermar fue significativamente más alto en Villa Clara, Matanzas, Ciudad de La Habana e Isla de la Juventud, mientras que el mayor riego de morir se observó en Granma, Ciudad de La Habana, Holguín e Isla de la Juventud. En mujeres el riesgo de enfermar no mostró diferencias regionales significativas mientras que el riesgo de morir fue significativamente más alto en Pinar del Río. Conclusiones Las diferencias regionales de enfermar y morir por cáncer de laringe pueden sugerir diagnósticos más tardíos y tratamientos menos oportunos en algunas provincias. Estos hallazgos deben alertar a las autoridades sanitarias, fundamentalmente en lo que respecta a la revisión del cumplimiento de las guías de diagnóstico y tratamiento y al desarrollo de planes de actualización y formación de profesionales.


Introduction Cuba is one of the countries with the highest rates of incidence of and mortality from laryngeal cancer. Objectives To identify the geographical distribution of the incidence of and mortality from laryngeal cancer in the 1999-2004 period. Methods The new cases reported to the National Register of Cancer from 1999 to 2003 as well as the deaths occured in the period of 2000 to 2004 were taken into consideration. Age-standardized average incidence and mortality rations for both periods were estimated. The standard risk was the specific average incidence and mortality rates by age groups in Cuba for the respective periods. The cartographic representation of the estimated risk was made. Results The risk of getting sick and dying was higher in men than in women. Regarding men, the risk of getting sick was significantly higher in Villa Clara, Matanzas, Ciudad de la Habana and Isla de la Juventud whereas the highest risk of dying was observed in Gramma, Ciudad de La Habana, Holguín and Isla de la Juventud. The risk of getting sick for women did not show significant regional differences whereas the risk of dying was substantially higher in Pinar del Río. Conclusions The regional differences in the risk of getting sick and dying from laryngeal cancer may suggest that later diagnosis and less timely therapies in some provinces could have been the causes. These findings should be an alert to the health authorities in terms of the review of the compliance with diagnosis and treatment guidelines and the development of professional formation and updating programs.


Subject(s)
Laryngeal Neoplasms/epidemiology , Laryngeal Neoplasms/mortality
18.
Rev. bras. otorrinolaringol ; 75(2): 222-227, mar.-abr. 2009. ilus, graf, tab
Article in Portuguese, English | LILACS | ID: lil-517160

ABSTRACT

A laringe é considerada o sítio de maior ocorrência de neoplasias na região de cabeça e pescoço, e para os estudos do câncer a mortalidade constitui-se um dos indicadores de saúde mais confiáveis OBJETIVO: Estudar a mortalidade por câncer de laringe em Pernambuco no período 2000-2004. FORMA DE ESTUDO: Estudo de coorte contemporânea com corte transversal. MATERIAL E MÉTODOS: Considerou-se o universo dos óbitos por câncer de laringe, em residentes do estado de Pernambuco entre 2000 e 2004, extraídos do Sistema de Informações sobre Mortalidade (SIM/SUS). A análise dos dados foi realizada através de estatística descritiva com resultados expressos em tabelas, gráficos e mapa, utilizando o software Excel versão 2000 e o software EpiInfo, versão 6.04b. RESULTADOS: Existiu pouca variação do coeficiente de mortalidade entre os anos estudados. A mesorregião do Sertão concentrou o agregado com o maior número de óbitos e Fernando de Noronha apresentou a maior taxa de mortalidade. O perfil encontrado foi de homens entre 60-69 anos, pardos, casados, com baixo grau de escolaridade, cujo óbito aconteceu em ambiente hospitalar. CONCLUSÃO: Ocorreu estabilidade da mortalidade e heterogeneidade entre os municípios. O perfil da mortalidade segundo variáveis sociais corrobora com outros estados brasileiros, exceto pela raça/cor.


The larynx is considered a site of the greatest occurrence of head and neck neoplasias, and for cancer studies, mortality is one of the most reliable health indicators. AIM: to study the mortality by laryngeal cancer in Pernambuco during 2000-2004. STUDY FORMAT: contemporary cross-sectional cohort. MATERIALS AND METHODS: we considered all deaths by laryngeal cancer in residents of Pernambuco State between 2000 and 2004, taken from the State's Mortality Information System (SIM/SUS). The data was analyzed through descriptive statistics, with the results expressed in tables, graphs and maps, using Excel version 2000 and the EpiInfo version 6.04b software. RESULTS: There was little variation in the mortality coefficient in the years considered for study. The Sertão Mesoregion had the highest number of deaths and Fernando de Noronha island had the highest mortality rate. The patient profile found was: men, between 60-69 years, brown color, married, with low literacy, who died in a hospital setting. CONCLUSION: we found mortality stability and heterogeneity among the cities. The mortality profile according to social variables corroborates data found in other Brazilian States, except for race/color.


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult , Laryngeal Neoplasms/mortality , Age Distribution , Brazil/epidemiology , Cross-Sectional Studies , Educational Status , Forecasting , Mortality/trends , Sex Factors , Young Adult
19.
Rev. otorrinolaringol. cir. cabeza cuello ; 68(2): 117-123, ago. 2008. graf, tab
Article in Spanish | LILACS | ID: lil-503436

ABSTRACT

Introducción: La laringectomía parcial y la radioterapia son alternativas eficaces en el tratamiento de pacientes con cáncer laríngeo precoz, comparables tanto en tasas de sobrevida como en conservación laríngea. Objetivo: Se describe la experiencia del primer autor en los últimos 25 años. Material y método: Estudio retrospectivo de pacientes con cáncer laríngeo precoz tratados entre los años 1980 y 2005. Se analiza los antecedentes de los pacientes, tipo de tratamiento, histología del tumor, complicaciones y tasas de sobrevida. Resultados: Se incluye un total de 96 pacientes, con una edad promedio de 58 años. El tipo histológico más frecuente fue el carcinoma epidermoide (92%). El 53% se sometió a cirugía laríngea parcial y 47% a radioterapia. La intervención más habitual fue la laringectomía frontolateral (68%). Las complicaciones más frecuentes fueron la presencia de granulomas (16%) y falta de cierre del traqueostoma (16%). Se constató recidiva en 4 pacientes tratados con radioterapia y 1 sometido a cirugía. La sobrevida actual es de 91% para quienes recibieron radioterapia y 100 por ciento en quienes se practicó laringectomía parcial. Se presenta los resultados del tratamiento con o sin compromiso de la comisura anterior. Discusión y conclusiones: La experiencia con ambas modalidades son comparables a la literatura, con complicaciones y secuelas esperables. La aparición de nuevas técnicas debe compararse en su realidad local con las terapias establecidas y la decisión terapéutica sigue correspondiendo a un acuerdo informado entre el tratante y su paciente.


Introduction. Partial laryngectomy and radiotherapy are good alternatives for early laryngeal cancer, as they are similar in both survival rate and laryngeal preservation. Aim. The first author's 25-year experience on this subject is described. Material and method. Retrospective review of early laryngeal cancer patients treated between 1980 and 2005. History type of treatment, tumor histology complications and survival rates are analyzed. Results. A total of 96 patients is included, with an average age of 58 years. The most frequent histological type was epidermoid carcinoma (92%). 53% of patients had partial laryngectomy, and 47% had radiotherapy. Most patients had a fronto-lateral laryngectomy (68%), and the most frequent complications were granulomas (16%) and failure of tracheostoma closure (16%). Four radiotherapy patients and one that underwent surgery had recurrences. Present survival rate is 91% for radiotherapy and 100% for partial laryngectomy. Treatment results with and without anterior comissure involvement are presented. Discussion and conclusions. Our experience with both treatment alternatives is comparable to that reponed in the literature, with similar complications. New techniques must be compared with those currently used, taking into account local reality and the therapeutic decision is still an informed agreement between the treating physician and the patient.


Subject(s)
Humans , Male , Female , Middle Aged , Carcinoma/surgery , Carcinoma/radiotherapy , Laryngectomy/methods , Laryngeal Neoplasms/surgery , Laryngeal Neoplasms/radiotherapy , Carcinoma/mortality , Postoperative Complications , Retrospective Studies , Laryngeal Neoplasms/mortality , Recurrence , Survival Rate
20.
Rev. bras. otorrinolaringol ; 73(6): 816-825, nov.-dez. 2007. graf, tab
Article in English, Portuguese | LILACS | ID: lil-474419

ABSTRACT

O tratamento do carcinoma da laringe tem como desafio a cura do paciente e a preservação do órgão. OBJETIVO: A avaliação dos subsítios na disseminação do carcinoma e a sua influência no tratamento cirúrgico da laringe, no controle local e na sobrevida. MATERIAL E MÉTODO: Cento e sessenta pacientes tratados na Escola Paulista de Medicina - Hospital São Paulo, no período de janeiro de 1998 a dezembro de 2004, foram compilados para análise da disseminação do carcinoma dos subsítios da laringe. Foram incluídos pacientes com seguimento mínimo de 2 anos, após diagnóstico e tratamento. A avaliação estatística foi: Teste X2, Teste de Fisher e a Curva de Kaplan-Meier. Forma de Estudo: Estudo de Coorte Histórica Longitudinal (Trabalho Clínico Retrospectivo). RESULTADOS: A comissura posterior e a infraglote, respectivamente, foram significantes para a laringectomia total: tumores glóticos AC: (p=0,03) AP: (p=0,0001); AC: (p=0,0007) AP: (p<0,0001). A infraglote foi significante nos tumores G+SG na AP: (p=0,04), e na taxa de óbitos AP: (p=0,03). CONCLUSÃO: A laringectomia total é o tratamento de eleição na presença de alto comprometimento da comissura posterior e da infraglote. Esta última pode comprometer a sobrevida, conforme a invasão local, mesmo na presença de margens cirúrgicas livres.


The present study aimed at assessing the other sites as the carcinoma spreads, as well as therapeutic results, in larynx preservation and patient survival. STUDY TYPE: It is a Longitudinal Historical Cohort Study, a retrospective clinical study. MATERIALS AND METHODS: A hundred and sixty (160) patients treated at ‘Escola Paulista de Medicina’ (‘Paulista’ Medical School) - São Paulo Hospital, from January 1988 to December 2004 were examined as for the spreading of their larynx carcinoma. Those patients whose evaluations were at least two years old after treatment were the only ones accepted. The parametric tests used were: Test X2, Fisher’s test, and Kaplan-Meier’s curve. RESULTS: The posterior commissure and the infraglottis were significant in terms of the laryngectomy: glottal tumors AC: (p=0.03) AP: (p=0.0001); AC: (p=0.0007) AP: (p<0.0001), respectively. The infraglottis was significant in G+SG tumors in AP: (p=0.04) and in death rate AP: (p=0.03). CONCLUSION: total laryngectomy is the treatment of choice in the presence of total involvement of the posterior commissure and the infraglottis. The latter may compromise survival, according to local invasion, even in the presence of free surgical margins.


Subject(s)
Male , Middle Aged , Humans , Female , Carcinoma, Squamous Cell/surgery , Laryngeal Neoplasms/surgery , Carcinoma, Squamous Cell/mortality , Follow-Up Studies , Kaplan-Meier Estimate , Laryngectomy , Neoplasm Staging , Laryngeal Neoplasms/mortality , Prognosis , Retrospective Studies , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL